Log in

Relevant bibliographies by topics / Drug eruption / Journal articles

To see the other types of publications on this topic, follow the link: Drug eruption.

Journal articles on the topic 'Drug eruption'

Author: Grafiati

Published: 28 May 2022

Last updated: 30 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Drug eruption.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Stubb, S., H. Heikkilä, and K. Kauppinen. "Cutaneous reactions to drugs: a series of in-patients during a five-year period." Acta Dermato-Venereologica 74, no. 4 (1994): 289–91. http://dx.doi.org/10.2340/0001555574292294.

Full text

Abstract:

We have studied drug eruptions at a single clinic since 1956. The last 5-year series comprises in-patients with drug eruptions during the period 1986-1990. The total number of cases in this series was 135, the most common types being fixed eruption, exanthematous eruption and urticaria. The causative agent was confirmed with a provocation test in 102 cases. The most common groups of causative drugs were antimicrobial agents, anti-pyretic/anti-inflammatory analgesics and drugs acting on the central nervous system. We also present a 35-year series of 1997 cases of drug eruptions, most of them pr

APA, Harvard, Vancouver, ISO, and other styles

2

Darmani, Endang H., T. Sy Dessi Indah S As, Yuni Eka Anggraini, and Olivia Makmur. "Gambaran Karakteristik Pasien Erupsi Obat Alergi di RSUD Arifin Achmad Pekanbaru Periode 2010 – 2014." Jurnal Ilmu Kedokteran 10, no. 1 (2017): 67. http://dx.doi.org/10.26891/jik.v10i1.2016.67-70.

Full text

Abstract:

Allergic drug eruptions is one of most dermatology cases can find in Arifin Achmad General Hospital Pekanbaru forlast four years and study about the characteristic description of allergic drug eruption’s patients never been describedbefore. To describe the characteristic of allergic drug eruption’s patients in Arifin Achmad General Hospital PekanbaruIndonesia. This is a descriptive retrospective study with 35 subjects, which is describing the most common type ofmorphologic skin eruption, groups of gender and age were affected , and etiology drugs were suspected. Mostcommon type of morphologic

APA, Harvard, Vancouver, ISO, and other styles

3

Allchurch, L. G. V., and H. Crilly. "Fixed Drug Eruption to Propofol." Anaesthesia and Intensive Care 42, no. 6 (2014): 777–81. http://dx.doi.org/10.1177/0310057x1404200614.

Full text

Abstract:

We present a case of fixed drug eruption to propofol following a series of sedations of a patient for a number of day case procedures. The patient experienced oedema and blistering of his penis, increasing in severity and duration following each subsequent exposure. The diagnosis was confirmed by punch biopsy following an intravenous challenge test with propofol. Whilst reports of fixed drug eruptions to anaesthetic induction agents are uncommon, a number of drugs used commonly by anaesthetists are known triggers. We discuss fixed drug eruptions in relation to anaesthetic practice, aiming to r

APA, Harvard, Vancouver, ISO, and other styles

4

Kavoussi, Hossein, Mansour Rezaei, Katayoun Derakhshandeh, et al. "Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005–2014)." Dermatology Research and Practice 2015 (2015): 1–4. http://dx.doi.org/10.1155/2015/236703.

Full text

Abstract:

Background.Generalized fixed drug eruption is a specific variant of fixed drug eruption with multifocal lesions. Diagnosis of this drug reaction is straightforward, but occasionally recognition of the causative drug is not possible. This study was aimed at evaluating the clinical features and culprit drugs in generalized fixed drug eruptions in the west of Iran.Method.This cross-sectional study was carried out on 30 patients with criteria of generalized fixed drug eruption over 9 years. Demographic, clinical, and drug intake information were collected.Results.Out of 30 patients (17 females and

APA, Harvard, Vancouver, ISO, and other styles

5

Wibisono, Yusuf, and Damayanti Damayanti. "Skin Test for Cutaneous Adverse Drug Reactions." Berkala Ilmu Kesehatan Kulit dan Kelamin 32, no. 1 (2020): 62. http://dx.doi.org/10.20473/bikk.v32.1.2020.62-69.

Full text

Abstract:

Background: The incidence of drug eruptions is increasing during the last few years due to a large number of new medications. Early detection of the causative agent and the prevention from exposure are crucial managements in terms of drug eruption, mainly to prevent its recurrence. Objective: To understand skin test as a diagnostic modality in drug eruption, which includes skin patch test, skin prick test, and intradermal test. Literature review: Drug eruption is a form of skin eruption triggered by the use of medications, topical or systemic, in the right dose and indication. The manifestatio

APA, Harvard, Vancouver, ISO, and other styles

6

Mohammed, Fayeza, Laura L. Wally, Jeffrey E. Karaban, Vijaya B. Reddy, and Yongsuk Lertratanakul. "Fenofibrate-Induced Lichenoid Drug Eruption: A Rare Culprit." Case Reports in Dermatology 9, no. 3 (2017): 236–42. http://dx.doi.org/10.1159/000484471.

Full text

Abstract:

A lichenoid drug eruption is a rare side effect which can occur following the administration of several different medications. Here we describe a unique case of fenofibrate as the causative agent of a lichenoid drug eruption. This case highlights a rare and clinically significant dermatologic side effect of fenofibrate. In addition, we report a potential familial association which underscores the potential for underlying genetic mechanisms to be contributory to lichenoid drug eruptions. A reminder of the physical characteristics of lichen planus, knowledge of the temporal relation between admi

APA, Harvard, Vancouver, ISO, and other styles

7

Lee, Eun Hye, and Yong Hyun Jang. "Cutaneous adverse drug reactions." Journal of the Korean Medical Association 66, no. 1 (2023): 41–47. http://dx.doi.org/10.5124/jkma.2023.66.1.41.

Full text

Abstract:

Background: Cutaneous adverse drug reactions are common and produce easily identifiable clinical symptoms. These may range from mild maculopapular rashes to severe reactions associated with systemic disease.Current Concepts: The most common presentation of a drug eruption is in the form of a maculopapular rash or exanthematous skin eruption, followed by fixed drug eruptions and urticaria. Severe cutaneous adverse drug reactions include Stevens-Johnson syndrome/toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug-induced hypersensitivity syndrome/drug reaction with e

APA, Harvard, Vancouver, ISO, and other styles

8

Emperumal, Tamil Selvi. "Drug induced bullous fixed drug eruption: a case report." International Journal of Basic & Clinical Pharmacology 13, no. 3 (2024): 398–99. http://dx.doi.org/10.18203/2319-2003.ijbcp20241001.

Full text

Abstract:

Bullous fixed drug eruption, which is a cutaneous adverse drug reaction, is commonly seen with antimicrobials and analgesics. Bullous drug eruptions are infrequent, but because they pose a challenge both to affected patients and to treating physicians, they are considered to be the most severe cutaneous adverse reactions (SCAR). It is important to recognize these conditions and to differentiate them from other clinical entities involving blister formation. There may be early signs and symptoms that indicate a severe bullous drug eruption even before blisters and erosions of the skin and mucous

APA, Harvard, Vancouver, ISO, and other styles

9

Amine, Ennaciri Mohamed, Basri Ghita, Zemmez Youssef, et al. "Metformin Induced Lichenoïd Drug Eruption." Scholars Journal of Medical Case Reports 12, no. 12 (2024): 2048–51. https://doi.org/10.36347/sjmcr.2024.v12i12.011.

Full text

Abstract:

Cutaneous lichenoid drug eruptions are rare adverse drug reactions reminiscent of lichen planus. The most frequently reported culprit drugs are Checkpoint inhibitors, tyrosine kinase inhibitors and TNF-α inhibitors, but other drugs can also be responsible. This case-report is about a 49-year-old woman with a history of type 2 diabetes. She started taking metformin 160 weeks before the onset of a pruritic lichenoid rash on the trunk and limbs, of which the histopathology was in favor of an adverse cutaneous lichenoid drug eruption caracterized by the presence of eosinophilic polynuclei in the p

APA, Harvard, Vancouver, ISO, and other styles

10

Büyükgebiz, Benal, Nur Arslan, Yeşim Oztürk, Cüneyt Soyal, and Banu Lebe. "Drug Reaction To Ursodeoxycholic Acid: Lichenoid Drug Eruption In An Infant Using Ursodeoxycholic Acid For Neonatal Hepatitis." Journal of Pediatric Gastroenterology and Nutrition 35, no. 3 (2002): 384–86. http://dx.doi.org/10.1002/j.1536-4801.2002.tb07842.x.

Full text

Abstract:

ABSTRACTLichenoid drug eruptions are skin reactions associated with a number of drugs and chemicals. They are rare in infants. We report here an infant who presented with neonatal hepatitis and who was being treated with ursodeoxycholic acid. The infant developed lichenoid skin eruptions in the third week of the therapy. The lesions have resolved two months after the discontinuation of the drug. To our knowledge, this is the first infant case of lichenoid drug eruption associated with ursodeoxycholic acid.

APA, Harvard, Vancouver, ISO, and other styles

11

Kovacs, Timea, Christopher Davidson, Kacey Gibson, and Jennifer Richardson. "Non-Pigmenting Fixed Drug Eruption Due to Fluconazole Without Cross-Reactivity to Itraconazole." SKIN The Journal of Cutaneous Medicine 7, no. 6 (2023): 1191–94. http://dx.doi.org/10.25251/skin.7.6.20.

Full text

Abstract:

Fixed drug eruption is an uncommon cutaneous skin reaction that is most frequently attributed to antibiotics, non-steroidal anti-inflammatories, and paracetamol. Localized hyperpigmentation often results after the resolution of acute inflammation. Rarely, do fixed drug eruptions resolve without hyperpigmentation. Non-pigmenting fixed drug eruption (NPFDE) is an uncommon subtype that is characterized by well-demarcated, tender erythematous plaques that resolve without post-inflammatory hyperpigmentation. NPFDE has most frequently been associated with pseudoephedrine and piroxicam, but we report

APA, Harvard, Vancouver, ISO, and other styles

12

Keshari, Adarsh, Kriti Jain, Roshan Pandey, et al. "Review on Bullous Pemphigoid: Fixed Drug Eruption or Autoimmune Disorder." Journal of Pharmaceutical Technology, Research and Management 12, no. 2 (2024): 15–24. https://doi.org/10.15415/jptrm.2024.122002.

Full text

Abstract:

Background: Bullous pemphigoid is a blistering disease of autoimmune nature predominantly affecting the geriatric population. It is characterized by blister formation at the subepidermal level, due to autoantibodies at the dermo-epidermal junction targeting proteins BP180XV11 and BP230. Mainly an autoimmune condition, diagnosis and treatment get complicated as it overlaps with drug-induced hypersensitivity reactions, including fixed drug eruption. Unlike Bullous Pemphigoid, it is a condition of localized hypersensitivity mediated by T cells. Purpose: The review tries to establish Bullous Pemph

APA, Harvard, Vancouver, ISO, and other styles

13

Neeraj, Srivastav, Goel Mani, Kaushik Sadhna, and Kumar Vinay. "Fixed Drug Eruption: A Case Series." International Journal of Toxicological and Pharmacological Research 14, no. 8 (2024): 69–73. https://doi.org/10.5281/zenodo.13827773.

Full text

Abstract:

<strong>Background and Objectives: </strong>Fixed Drug Eruption (FDE), is a mucocutaeous eruption occurring as a part of adverse drug reaction. They are often localised, well defined, and reoccur on the same sites upon restarting the drug. Here, we are reporting a case series of 309 patients who developed FDE after consuming these commonly used drugs. <strong>Methods:</strong> This study was conducted at the dermatology outpatient department (OPD) in collaboration with the Adverse Drug Reaction (ADR) Monitoring Centre of the pharmacology department of MLB Medical College, Jhansi

APA, Harvard, Vancouver, ISO, and other styles

14

Choi, You Won. "Drug Eruption." Ewha Medical Journal 35, no. 2 (2012): 76. http://dx.doi.org/10.12771/emj.2012.35.2.76.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

George, Adekunle O., and Adebola O. Ogunbiyi. "Fixed drug eruption and fixed drug-like eruption." International Journal of Dermatology 44, no. 4 (2005): 349–50. http://dx.doi.org/10.1111/j.1365-4632.2005.02323.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Salgado, N., S. Benavente, J. M. Coll, and A. Vives. "Drug eruption due to bupropion, a case report." European Psychiatry 33, S1 (2016): S619—S620. http://dx.doi.org/10.1016/j.eurpsy.2016.01.2317.

Full text

Abstract:

IntroductionWe present a clinical case of eruption caused by the use of bupropion. Bupropion is known to cause hypersensitivity reactions.Case reportWe report the case of a 48-year-old female who was diagnosed of depressive disorder. She went to emergency because a few days after prescribing bupropion (150 mg/24 h) scaly skin eruptions were found distributed along the skin. In the present case, after its introduction, bupropion was found to be a probable etiological agent. The patient was successfully treated with corticosteroids. Because of that, bupropion dosage was stopped and replaced with

APA, Harvard, Vancouver, ISO, and other styles

17

Goldenberg, Michael, Morgan Amigo, Somashekar G. Krishna, Nima Milani-Nejad, John C. Trinidad, and Benjamin H. Kaffenberger. "Validation of Rash and Nonspecific Eruption Diagnoses Using ICD-9 and ICD-10 Codes." Academic Dermatology 1, no. 1 (2023): 1–2. http://dx.doi.org/10.18061/ad.v1i1.8860.

Full text

Abstract:

Despite being common cutaneous findings in the hospital setting, cutaneous drug eruptions have not been thoroughly validated for administrative claims data. The purpose of this study was to validate primary discharge diagnoses for the ICD code rash or other nonspecific eruptions by finding the positive predictive value (PPV) and to determine how often it was used to indicate an eruption that was eventually determined to be a drug eruption. Two dermatologists independently examined each of 39 hospital patient encounters to assess the validity of the ICD code used by stating whether the code use

APA, Harvard, Vancouver, ISO, and other styles

18

Vikramjeet, Singh, Batta Angelika, and Malik Nishtha. "Norfloxacin Induced Recurrent Fixed Drug Eruption in a self Treated Adult Female Patient - A Case Report." Current Drug Safety 14, no. 1 (2019): 72–76. http://dx.doi.org/10.2174/1574886313666180807095559.

Full text

Abstract:

Background: Fixed drug eruption is a clinical entity occurring at the same site each time the drug is administered. They are usually found on lips, genitalia, abdomen, and legs but can occur at any location. The eruptions usually occur within hours of administration of the drug and resolves spontaneously. Most common drugs causing them include antimicrobials. Fluroquinolones especially norfloxacin is commonly used in the treatment of gastrointestinal infections. Cutaneous adverse drug reactions are very rare with norfloxacin. Case Report: In this case report, a young female, soon after taking

APA, Harvard, Vancouver, ISO, and other styles

19

Liu, Xinyuan. "Drug trade analysis model based on location judgment." Highlights in Science, Engineering and Technology 11 (August 23, 2022): 27–37. http://dx.doi.org/10.54097/hset.v11i.1263.

Full text

Abstract:

According to the current spread of new drug problem, this paper established the blocks the growth model of correction, to complete the determination of drug eruption time node, then based on the geographical position the drug eruption time model is established in this paper, using the fisher discriminant method, by geographical location, the estimated time of drug eruption and USES the multi-layer perceptron neural network to predict counties of drug eruption time, Finally, the robustness analysis is completed. This article establishes drugs.

APA, Harvard, Vancouver, ISO, and other styles

20

T. S., Rajashekar, Shruthi Madhavi G., and Suresh Kumar Kuppuswamy. "Imatinib mesylate induced lichenoid drug eruption masquerading as small plaque parapsoriasis." International Journal of Research in Dermatology 4, no. 2 (2018): 262. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20181832.

Full text

Abstract:

<p class="abstract">Imatinib mesylate (IM) is a tyrosine kinase inhibitor approved for chronic myeloid leukemia, gastrointestinal stromal tumor and few dermatological conditions such as dermatofibrosarcoma protruberans, systemic sclerosis and systemic mastocytosis among other conditions. It is known to cause non lichenoid eruptions commonly and rarely it can cause lichenoid drug eruption. Small plaque parapsoriasis is a monoclonal T cell disorder with clinical similarity to psoriasis characterised by small sized plaques with digitate appearance.We report a case of 75 year old male on IM

APA, Harvard, Vancouver, ISO, and other styles

21

Prabhu, Swathi C., and Harshavardhan K. Shetty. "A case of self-treatment induced oral mucosal fixed drug eruptions associated with use of tinidazole - a case report." International Journal of Research in Medical Sciences 9, no. 6 (2021): 1794. http://dx.doi.org/10.18203/2320-6012.ijrms20212256.

Full text

Abstract:

Fixed drug eruptions (FDE) is a type of adverse reaction to drugs encountered in medical practice. Skin, glans penis is most common site of involvement. We hereby report a case of fixed drug eruption on oral mucosa due to tinidazole, a nitroimidazole-derivative which the patient had taken as he was suffering from gastro-intestinal distress. Very limited case reports have been found in literature with respect to tinidazole causing FDE.

APA, Harvard, Vancouver, ISO, and other styles

22

Sukandar, Elin Yulinah, Sri Hartini, and Putri Rizkita. "Penyakit Kulit Terinduksi Obat pada Pasien di Bagian Penyakit Kulit di Salah Satu Rumah Sakit di Kota Bandung." Acta Pharmaceutica Indonesia 38, no. 1 (2013): 11–18. http://dx.doi.org/10.5614/api.v38i1.5198.

Full text

Abstract:

Penyakit kulit terinduksi obat atau disebut juga drug eruption merupakan reaksi toksik yang menyebabkan gangguan pada kulit setelah penggunaan obat. Drug eruption merupakan reaksi obat yang paling umum ditemukan. Obat yang banyak menginduksi reaksi ini adalah antibiotik dan AINS (antiinflamasi non-steroid). Penelitian ini bertujuan untuk mengidentifikasi pola kejadian penyakit kulit terinduksi obat, menentukan obat yang paling banyak diduga sebagai penyebab, dan menentukan jenis penyakit kulit terinduksi obat yang paling banyak terjadi pada tahun 2009-2011 di salah satu rumah sakit pemerintah

APA, Harvard, Vancouver, ISO, and other styles

23

Balakrishna, Balakrishna, Souris Kondaveti, and Bhuvaneshwari Bhuvaneshwari. "FIXED DRUG ERUPTION." Journal of Evidence Based Medicine and Healthcare 2, no. 7 (2015): 936–38. http://dx.doi.org/10.18410/jebmh/2015/134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

SHIRAISHI, SATOSHI. "Lichenoid drug eruption." Nishi Nihon Hifuka 48, no. 3 (1986): 443–46. http://dx.doi.org/10.2336/nishinihonhifu.48.443.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

SHIMIZU, Chihiro, Hiroyoshi HANAKAWA, and Norio OHTSUKI. "Lichenoid Drug Eruption." Nishi Nihon Hifuka 60, no. 4 (1998): 494–97. http://dx.doi.org/10.2336/nishinihonhifu.60.494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Chou, Yu-Ju, and Hua-Ching Chang. "Fixed drug eruption." Canadian Medical Association Journal 194, no. 29 (2022): E1036. http://dx.doi.org/10.1503/cmaj.220049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Fife, Donna Poma. "Cutaneous Drug Eruption." Journal of the Dermatology Nurses' Association 1, no. 6 (2009): 345–49. http://dx.doi.org/10.1097/jdn.0b013e3181c4f7b0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Valente Duarte de Sousa, Isabel Cristina. "Fixed Drug Eruption." New England Journal of Medicine 365, no. 6 (2011): e12. http://dx.doi.org/10.1056/nejmicm1013871.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Sehgal, Virender N., and Om P. Gangwani. "Fixed Drug Eruption." International Journal of Dermatology 26, no. 2 (1987): 67–74. http://dx.doi.org/10.1111/j.1365-4362.1987.tb00522.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Shiohara, Tetsuo. "Fixed Drug Eruption." Archives of Dermatology 125, no. 10 (1989): 1371. http://dx.doi.org/10.1001/archderm.1989.01670220067010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Wolf, R., S. Brenner, and A. Krakowski. "Intertriginous drug eruption." Acta Dermato-Venereologica 72, no. 6 (1992): 441–42. http://dx.doi.org/10.2340/0001555572441442.

Full text

Abstract:

Presented are two patients who developed an unusual, and as yet unreported eruption due to amoxycillin. They exhibited an eruption confined to the intertriginous areas, which mimicked intertrigo. Although drug eruption can mimic a variety of idiopathic skin diseases, intertrigo is easily distinguished from drug eruption and has not been mentioned in the differential diagnosis of this reaction. It is suggested that drug reactions should be considered in the differential diagnosis of intertrigo, in particular of atypical and therapy-resistant cases. Early detection of these cases has practical i

APA, Harvard, Vancouver, ISO, and other styles

32

KOGA, Tetsuya. "Identification of drugs causing drug eruption." Nishi Nihon Hifuka 61, no. 6 (1999): 715–18. http://dx.doi.org/10.2336/nishinihonhifu.61.715.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

West, Dennis P., and Jean A. Rumsfield. "Cutaneous Manifestations of Adverse Drug Reactions." Journal of Pharmacy Practice 2, no. 4 (1989): 251–55. http://dx.doi.org/10.1177/089719008900200409.

Full text

Abstract:

immune-mediated cutaneous reactions to drugs are usually categorized into four distinct types: Type 1, immediate; Type 11, cytotoxic; Type III, immune-complex: and Type IV, cell-mediated. Nonimmunologic skin reactions are also recognized. Beyond immune vnonimmune classifications, cutaneous drug reactions are generally described according to morphologic patterns of reaction. Common types of reactivity usually include maculopapular and urticarial eruptions. In addition, less common reactions include fixed drug eruption, hyperpigmentation, vasculitis, erythema multiforme, toxic epidermal necrolys

APA, Harvard, Vancouver, ISO, and other styles

34

Bjekic, Milan, Milica Markovic, and Sandra Sipetic. "Fixed drug eruption caused by tadalafil - case report." Anais Brasileiros de Dermatologia 88, no. 4 (2013): 617–19. http://dx.doi.org/10.1590/abd1806-4841.20131994.

Full text

Abstract:

Fixed drug eruptions (FDE) are commonly reported type of mucocutaneous drug eruption. The aim of this paper is to present a patient with multiple mucocutaneous erythema fixum type lesions caused by oral tadalafil use. A short course of topical corticosteroid therapy resulted in complete resolution of all lesions leaving residual hyperpigmentation of the involved skin sites. Mucosal oral lesions were effectively treated with gingival hyaluronic acid 0.2% gel. Conclusion: when assessing a patient of any age with drug eruptions, a thorough personal history should be obtained, in particular data o

APA, Harvard, Vancouver, ISO, and other styles

35

Fischer, Daniel, Joseph Gofman, Graham Litchman, and Sourab Choudhury. "Identifying a Case of an Atenolol-induced Papulosquamous Eruption." SKIN The Journal of Cutaneous Medicine 8, no. 3 (2024): 1537–41. http://dx.doi.org/10.25251/skin.8.3.10.

Full text

Abstract:

While beta-adrenergic blocking agents (beta blockers) are generally safe, their incidence of medication-induced cutaneous eruptions remain under-recognized in the primary care setting. The adverse dermatologic effects of these medications may arise in the days to years following drug initiation, contributing to its delayed diagnosis and management. Here we report a case of a papulosquamous drug eruption in an older adult due to atenolol. We also discuss pertinent morphologic findings, diagnostic methods, management, and how to distinguish this type of eruption from other papulosquamous disorde

APA, Harvard, Vancouver, ISO, and other styles

36

Kunadia, Anuj, Kenneth Shulman, and Naveed Sami. "Certolizumab-induced lichenoid eruption in a patient with rheumatoid arthritis." BMJ Case Reports 14, no. 12 (2021): e245875. http://dx.doi.org/10.1136/bcr-2021-245875.

Full text

Abstract:

Certolizumab is a monoclonal antibody against tumour necrosis factor-alpha (TNF-α) commonly used in rheumatologic conditions such as rheumatoid arthritis. Skin rashes are an uncommon side effect with few cases of lichenoid drug eruption reported in the literature. We describe a patient with rheumatoid arthritis who presented 6 weeks after initiating certolizumab pegol. Physical examination showed pink-to-violaceous papules on her upper and lower extremities. Biopsy confirmed a lichenoid drug eruption. The medication was discontinued and she was treated with topical steroids and a calcineurin i

APA, Harvard, Vancouver, ISO, and other styles

37

Adams, Amy E., Arthur M. Bobrove, and Anita C. Gilliam. "Statins and “Chameleon-Like” Cutaneous Eruptions: Simvastatin-Induced Acral Cutaneous Vesiculobullous and Pustular Eruption in a 70-Year-Old Man." Journal of Cutaneous Medicine and Surgery 14, no. 5 (2010): 207–11. http://dx.doi.org/10.2310/7750.2010.09042.

Full text

Abstract:

Background: The statin medications for lowering of blood cholesterol can be associated with cutaneous lichenoid reactions but also a variety of other adverse cutaneous eruptions, including Stevens-Johnson syndrome, toxic epidermolytic necrolysis, porphyria cutanea tarda, linear IgA bullous dermatosis, and reaction patterns (lupus and dermatomyositis-like and pustular). Cutaneous eruptions (“eczema” in the product literature) owing to simvastatin are reported in approximately 1.5% individuals compared with placebo. Objective: To correlate the clinical and microscopic features of an unusual vesi

APA, Harvard, Vancouver, ISO, and other styles

38

Gani, Azhari, and Muhammad Jailani. "Fixed Drug Eruption: Case Report." Britain International of Exact Sciences (BIoEx) Journal 2, no. 3 (2020): 697–708. http://dx.doi.org/10.33258/bioex.v2i3.310.

Full text

Abstract:

Drug allergy is characterized by hypersensitivity reactions to pharmacological agents, having an immune mechanism of development. In these reactions antibody and/or activated T cells are directed against medications or their metabolites. This problem is rather urgent for practical healthcare, as over 7% of people suffer from drug allergy. A 54-year old male presented at the emergency room Hospital Zainoel Abidin with redness and swelling of the bodies of a burning sensation, itching pain. In the detailed anamnesis taken from the patient, it was learned that 1 days previously he had consulted a

APA, Harvard, Vancouver, ISO, and other styles

39

Das, Sudip, Sujata Sinha, and Abhishek De. "Postcoital fixed drug eruption: A rare pattern of fixed drug eruption." Indian Journal of Drugs in Dermatology 6, no. 1 (2020): 35. http://dx.doi.org/10.4103/ijdd.ijdd_54_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Nguyen, Kevin, Diem Q. Pham, and Christof P. Erickson. "Psoriasiform Spongiotic Dermatitis Drug Eruption following Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine Administration." SKIN The Journal of Cutaneous Medicine 7, no. 2 (2023): 727–31. http://dx.doi.org/10.25251/skin.7.2.13.

Full text

Abstract:

Introduction: Cutaneous manifestations such as morbilliform rashes, lichen planus, and local injection site patches have been recently published in case reports to occur within days of receiving the coronavirus disease 2019 (COVID-19) vaccine. The most common drug eruptions have been noted to be delayed hypersensitivity reactions. Objective: To spotlight a vaccine drug eruption case in a patient with a long history of the autoimmune condition, psoriasis vulgaris. Case Presentation: A 51-year-old Caucasian female presented with pruritic and erythematous rashes covering her back, abdomen, pelvis

APA, Harvard, Vancouver, ISO, and other styles

41

Onodera, Mikoto, Yoshihiro Muragaki, Atsushi Fukui, et al. "COT-31 Risk Factors for the Development of Skin Rash with Levetiracetam and Lacosamide in Patients with Glioma." Neuro-Oncology Advances 3, Supplement_6 (2021): vi31. http://dx.doi.org/10.1093/noajnl/vdab159.123.

Full text

Abstract:

Abstract Introduction: Seizure control of in glioma patients is essential for quality of life. The new generation anti-seizure drug (ASD) is represented by lacosamide (LCM) and levetiracetam (LEV), and is said to have few side effects of eruption. We retrospectively analyzed the incidence of rash and related factors of the ASD, evaluated the safety of patients with glioma, and conducted a comparison with the evaluation of patients with meningioma. Method: We calculated the incidence of rash in patients who underwent glioma resection at our Hospital from January 2017 to December 2019 and were p

APA, Harvard, Vancouver, ISO, and other styles

42

Pursnani, Nikhil, Prabhat Agrawal, Ashish Gautam, Aqsa Jafri, and Sahil Vij. "A case series on fixed drug eruptions: Benign yet notorious." IP Indian Journal of Clinical and Experimental Dermatology 10, no. 2 (2024): 235–37. http://dx.doi.org/10.18231/j.ijced.2024.042.

Full text

Abstract:

Fixed Drug Eruption (FDE), is a mucocutaeous eruption occurring as a part of adverse drug reaction. They are often localised, well defined, and reoccur on the same sites upon restarting the drug. Here, we are reporting a case series of four patients who developed FDE after consuming these commonly used drugs.

APA, Harvard, Vancouver, ISO, and other styles

43

ZANOLLI, MICHAEL D., JOANNE MCALVANY, and DANIEL P. KROWCHUK. "Phenolphthalein-Induced Fixed Drug Eruption: A Cutaneous Complication of Laxative Use in a Child." Pediatrics 91, no. 6 (1993): 1199–201. http://dx.doi.org/10.1542/peds.91.6.1199.

Full text

Abstract:

Drug eruptions are a common dermatologic problem faced by pediatricians. Among the most distinctive of these is the fixed drug eruption, a cutaneous inflammatory reaction manifested by solitary or multiple, well-defined, erythematous macules that may become bullous.1,2 Lesions usually occur within a few hours of ingesting the drug, characteristically recur in the same location with each subsequent dose, and leave residual hyperpigmentation. To illustrate the importance and unique features of this unusual reaction, we report the case of a child who experienced a recurrent fixed drug eruption in

APA, Harvard, Vancouver, ISO, and other styles

44

Nishijima, S., and M. Nakagawa. "Fixed Drug Eruption Caused by Tosufloxacin Tosilate." Journal of International Medical Research 25, no. 6 (1997): 359–63. http://dx.doi.org/10.1177/030006059702500606.

Full text

Abstract:

A 39-year-old woman presented with a purple-red macula, 2 cm in diameter, on the back of her right hand. She had had similar maculae at this location several times before and residual pigmentation had persisted for 6 months. Histopathological examination showed slight acanthosis of the epidermis and perivascular round-cell infiltration and melanophages in the dermis. Oral provocation tests with five drugs that the patient had received as common-cold treatments on different occasions were positive only in the case of tosufloxacin; after an hour the skin lesion reappeared. To our knowledge this

APA, Harvard, Vancouver, ISO, and other styles

45

Hind, Palamino, Siham Belmourida, and Mariame Meziane. "Bullous fixed drug eruption." Our Dermatology Online 11, e (2020): e136.1-e136.2. http://dx.doi.org/10.7241/ourd.2020e.136.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Du-Thanh, Aurélie, Nicolas Kluger, Houdna Bensalleh, and Bernard Guillot. "Drug-Induced Acneiform Eruption." American Journal of Clinical Dermatology 12, no. 4 (2011): 233–45. http://dx.doi.org/10.2165/11588900-000000000-00000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Salloum, Antoine, Dayana Nasr, and Diane Maalouf. "Esomeprazole fixed drug eruption." Contact Dermatitis 82, no. 5 (2020): 334–35. http://dx.doi.org/10.1111/cod.13479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Tan, Cheng, and Wen-Yuan Zhu. "Annular fixed drug eruption." JDDG: Journal der Deutschen Dermatologischen Gesellschaft 8, no. 10 (2010): 823–24. http://dx.doi.org/10.1111/j.1610-0387.2010.07385.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Waldman, Leah, Swathi B. Reddy, Andrea Kassim, Jennifer Dettloff, and Vijaya B. Reddy. "Neutrophilic Fixed Drug Eruption." American Journal of Dermatopathology 37, no. 7 (2015): 574–76. http://dx.doi.org/10.1097/dad.0000000000000157.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Armour, Katherine, and Patricia Lowe. "Complicated lichenoid drug eruption." Australasian Journal of Dermatology 46, no. 1 (2005): 21–24. http://dx.doi.org/10.1111/j.1440-0960.2005.00131.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!